MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
-981,208
Put/Call ratio
92%
SEC-reported price per share
$97.41
Number of holders
147
Value change
-$99,083,348
Number of buys
87
Open additional details 1 more signal available
Number of sells
50
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,822,754

Security key

558868105

Report period

Q2 2021

Institutions

147

Top holders

10

Ownership snapshot

Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 8.3% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 8.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Comparable ownership Top 5
Capital Research Global Investors 8.3%
BAKER BROS. ADVISORS LP 6.6%
Avoro Capital Advisors LLC 6.2%
VANGUARD GROUP INC 4.4%
BlackRock Finance, Inc. 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
8.3%
$221,432,000
1,893,066 shares
31 Mar 2021
BAKER BROS. ADVISORS LP
13F
Company
13F
6.6%
$175,363,000
1,499,213 shares
31 Mar 2021
Avoro Capital Advisors LLC
13F
Company
13F
6.2%
$166,682,000
1,425,000 shares
31 Mar 2021
VANGUARD GROUP INC
13F
Company
13F
4.4%
$116,713,000
997,809 shares
31 Mar 2021
BlackRock Finance, Inc.
13F
Company
13F
4.2%
$111,836,000
956,096 shares
31 Mar 2021
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.6%
$95,546,000
816,834 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
147
Shares
11,229,236
Rows available
147
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
135
Q2 2021 holders
147
Holder diff
12
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .